A citation-based method for searching scientific literature

Mark B Faries, John F Thompson, Alistair J Cochran, Robert H Andtbacka, Nicola Mozzillo, Jonathan S Zager, Tiina Jahkola, Tawnya L Bowles, Alessandro Testori, Peter D Beitsch, Harald J Hoekstra, Marc Moncrieff, Christian Ingvar, Michel W J M Wouters, Michael S Sabel, Edward A Levine, Doreen Agnese, Michael Henderson, Reinhard Dummer, Carlo R Rossi, Rogerio I Neves, Steven D Trocha, Frances Wright, David R Byrd, Maurice Matter, Eddy Hsueh, Alastair MacKenzie-Ross, Douglas B Johnson, Patrick Terheyden, Adam C Berger, Tara L Huston, Jeffrey D Wayne, B Mark Smithers, Heather B Neuman, Schlomo Schneebaum, Jeffrey E Gershenwald, Charlotte E Ariyan, Darius C Desai, Lisa Jacobs, Kelly M McMasters, Anja Gesierich, Peter Hersey, Steven D Bines, John M Kane, Richard J Barth, Gregory McKinnon, Jeffrey M Farma, Erwin Schultz, Sergi Vidal-Sicart, Richard A Hoefer, James M Lewis, Randall Scheri, Mark C Kelley, Omgo E Nieweg, R Dirk Noyes, Dave S B Hoon, He-Jing Wang, David A Elashoff, Robert M Elashoff. N Engl J Med 2017
Times Cited: 655







List of co-cited articles
552 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
Donald L Morton, John F Thompson, Alistair J Cochran, Nicola Mozzillo, Omgo E Nieweg, Daniel F Roses, Harold J Hoekstra, Constantine P Karakousis, Christopher A Puleo, Brendon J Coventry,[...]. N Engl J Med 2014
831
40

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, Werner Hohenberger, Norbert Brockmeyer, Carola Berking, Cord Sunderkötter, Martin Kaatz, Klaus-Werner Schulte, Percy Lehmann,[...]. Lancet Oncol 2016
358
36

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
Jeffrey Weber, Mario Mandala, Michele Del Vecchio, Helen J Gogas, Ana M Arance, C Lance Cowey, Stéphane Dalle, Michael Schenker, Vanna Chiarion-Sileni, Ivan Marquez-Rodas,[...]. N Engl J Med 2017
33

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Jeffrey E Gershenwald, Richard A Scolyer, Kenneth R Hess, Vernon K Sondak, Georgina V Long, Merrick I Ross, Alexander J Lazar, Mark B Faries, John M Kirkwood, Grant A McArthur,[...]. CA Cancer J Clin 2017
33

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S Carlino,[...]. N Engl J Med 2018
884
26

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Georgina V Long, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon,[...]. N Engl J Med 2017
745
26

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, Werner Hohenberger, Norbert H Brockmeyer, Carola Berking, Cord Sunderkötter, Martin Kaatz, Kerstin Schatton, Percy Lehmann,[...]. J Clin Oncol 2019
70
28

Technical details of intraoperative lymphatic mapping for early stage melanoma.
D L Morton, D R Wen, J H Wong, J S Economou, L A Cagle, F K Storm, L J Foshag, A J Cochran. Arch Surg 1992
16

Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
Donald L Morton, Alistair J Cochran, John F Thompson, Robert Elashoff, Richard Essner, Edwin C Glass, Nicola Mozzillo, Omgo E Nieweg, Daniel F Roses, Harald J Hoekstra,[...]. Ann Surg 2005
510
16

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
Sandra L Wong, Mark B Faries, Erin B Kennedy, Sanjiv S Agarwala, Timothy J Akhurst, Charlotte Ariyan, Charles M Balch, Barry S Berman, Alistair Cochran, Keith A Delman,[...]. J Clin Oncol 2018
123
14

Sentinel-node biopsy or nodal observation in melanoma.
Donald L Morton, John F Thompson, Alistair J Cochran, Nicola Mozzillo, Robert Elashoff, Richard Essner, Omgo E Nieweg, Daniel F Roses, Harald J Hoekstra, Constantine P Karakousis,[...]. N Engl J Med 2006
14

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.
Alexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, Reinhard Dummer, Jedd D Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo A Ascierto, Jon M Richards,[...]. Lancet Oncol 2015
778
14

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer,[...]. N Engl J Med 2019
13

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
12

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
Alexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, Reinhard Dummer, Jedd D Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo A Ascierto, Jon M Richards,[...]. N Engl J Med 2016
815
12

Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Paolo A Ascierto, Michele Del Vecchio, Mario Mandalá, Helen Gogas, Ana M Arance, Stephane Dalle, C Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion-Sileni,[...]. Lancet Oncol 2020
147
12

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Reinhard Dummer, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, John M Kirkwood, Vanna Chiarion Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux,[...]. N Engl J Med 2020
105
12

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Daniel G Coit, John A Thompson, Mark R Albertini, Christopher Barker, William E Carson, Carlo Contreras, Gregory A Daniels, Dominick DiMaio, Ryan C Fields, Martin D Fleming,[...]. J Natl Compr Canc Netw 2019
207
11

Improved overall survival in melanoma with combined dabrafenib and trametinib.
Caroline Robert, Boguslawa Karaszewska, Jacob Schachter, Piotr Rutkowski, Andrzej Mackiewicz, Daniil Stroiakovski, Michael Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier,[...]. N Engl J Med 2015
10

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski,[...]. N Engl J Med 2015
10

Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.
Domenico Bellomo, Suzette M Arias-Mejias, Chandru Ramana, Joel B Heim, Enrica Quattrocchi, Sindhuja Sominidi-Damodaran, Alina G Bridges, Julia S Lehman, Tina J Hieken, James W Jakub,[...]. JCO Precis Oncol 2020
45
22

Guidelines of care for the management of primary cutaneous melanoma.
Susan M Swetter, Hensin Tsao, Christopher K Bichakjian, Clara Curiel-Lewandrowski, David E Elder, Jeffrey E Gershenwald, Valerie Guild, Jane M Grant-Kels, Allan C Halpern, Timothy M Johnson,[...]. J Am Acad Dermatol 2019
188
9

Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
Jeffrey E Gershenwald, Richard A Scolyer. Ann Surg Oncol 2018
200
9

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.
Elisa A Rozeman, Alexander M Menzies, Alexander C J van Akkooi, Chandra Adhikari, Carolien Bierman, Bart A van de Wiel, Richard A Scolyer, Oscar Krijgsman, Karolina Sikorska, Hanna Eriksson,[...]. Lancet Oncol 2019
188
9

Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Dale Han, Jonathan S Zager, Yu Shyr, Heidi Chen, Lynne D Berry, Sanjana Iyengar, Mia Djulbegovic, Jaimie L Weber, Suroosh S Marzban, Vernon K Sondak,[...]. J Clin Oncol 2013
161
8

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
C M Balch, S J Soong, J E Gershenwald, J F Thompson, D S Reintgen, N Cascinelli, M Urist, K M McMasters, M I Ross, J M Kirkwood,[...]. J Clin Oncol 2001
8

Complications of sentinel lymph node biopsy for melanoma - A systematic review of the literature.
J A Moody, R F Ali, A C Carbone, S Singh, J T Hardwicke. Eur J Surg Oncol 2017
50
14

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
7

Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha,[...]. N Engl J Med 2015
7

Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Caroline Robert, Jacob Schachter, Georgina V Long, Ana Arance, Jean Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem,[...]. N Engl J Med 2015
7

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial.
Alexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, Reinhard Dummer, Jedd D Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo Antonio Ascierto, Jon M Richards,[...]. Eur J Cancer 2019
76
9

Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?
A C J van Akkooi, J H W de Wilt, C Verhoef, P I M Schmitz, A N van Geel, A M M Eggermont, M Kliffen. Ann Oncol 2006
210
7

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria G Atkinson, Stéphane Dalle, Andrew M Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S Carlino,[...]. J Clin Oncol 2020
93
7

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Michele Maio, Karl Lewis, Lev Demidov, Mario Mandalà, Igor Bondarenko, Paolo A Ascierto, Christopher Herbert, Andrzej Mackiewicz, Piotr Rutkowski, Alexander Guminski,[...]. Lancet Oncol 2018
115
7

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.
Alexander C Huang, Robert J Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M George, Patrick K Yan, Sasikanth Manne, Adam A Kraya, Bradley Wubbenhorst, Liza Dorfman,[...]. Nat Med 2019
275
7

Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.
Jeffrey E Gershenwald, Robert H I Andtbacka, Victor G Prieto, Marcella M Johnson, A Hafeez Diwan, Jeffrey E Lee, Paul F Mansfield, Janice N Cormier, Christopher W Schacherer, Merrick I Ross. J Clin Oncol 2008
153
7

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
Alexander M Menzies, Rodabe N Amaria, Elisa A Rozeman, Alexander C Huang, Michael T Tetzlaff, Bart A van de Wiel, Serigne Lo, Ahmad A Tarhini, Elizabeth M Burton, Thomas E Pennington,[...]. Nat Med 2021
81
8

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Rodabe N Amaria, Peter A Prieto, Michael T Tetzlaff, Alexandre Reuben, Miles C Andrews, Merrick I Ross, Isabella C Glitza, Janice Cormier, Wen-Jen Hwu, Hussein A Tawbi,[...]. Lancet Oncol 2018
143
7

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
O Michielin, A C J van Akkooi, P A Ascierto, R Dummer, U Keilholz. Ann Oncol 2019
180
7

Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
Carlo Riccardo Rossi, Simone Mocellin, Luca Giovanni Campana, Lorenzo Borgognoni, Serena Sestini, Giuseppe Giudice, Corrado Caracò, Adriana Cordova, Nicola Solari, Dario Piazzalunga,[...]. Ann Surg Oncol 2018
33
21

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
6

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609.
Ahmad A Tarhini, Sandra J Lee, F Stephen Hodi, Uma N M Rao, Gary I Cohen, Omid Hamid, Laura F Hutchins, Jeffrey A Sosman, Harriett M Kluger, Zeynep Eroglu,[...]. J Clin Oncol 2020
64
9

Melanoma.
Dirk Schadendorf, Alexander C J van Akkooi, Carola Berking, Klaus G Griewank, Ralf Gutzmer, Axel Hauschild, Andreas Stang, Alexander Roesch, Selma Ugurel. Lancet 2018
490
6

Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis.
Erin Cordeiro, Mai-Kim Gervais, Prakesh S Shah, Nicole J Look Hong, Frances C Wright. Ann Surg Oncol 2016
65
9

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
Sandra L Wong, Mark B Faries, Erin B Kennedy, Sanjiv S Agarwala, Timothy J Akhurst, Charlotte Ariyan, Charles M Balch, Barry S Berman, Alistair Cochran, Keith A Delman,[...]. Ann Surg Oncol 2018
74
8

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
Michael A Henderson, Bryan H Burmeister, Jill Ainslie, Richard Fisher, Juliana Di Iulio, B Mark Smithers, Angela Hong, Kerwin Shannon, Richard A Scolyer, Scott Carruthers,[...]. Lancet Oncol 2015
106
6

Final version of 2009 AJCC melanoma staging and classification.
Charles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, John F Thompson, Michael B Atkins, David R Byrd, Antonio C Buzaid, Alistair J Cochran, Daniel G Coit, Shouluan Ding,[...]. J Clin Oncol 2009
6

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
J E Gershenwald, W Thompson, P F Mansfield, J E Lee, M I Colome, C H Tseng, J J Lee, C M Balch, D S Reintgen, M I Ross. J Clin Oncol 1999
946
6

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
Rodabe N Amaria, Alexander M Menzies, Elizabeth M Burton, Richard A Scolyer, Michael T Tetzlaff, Robert Antdbacka, Charlotte Ariyan, Roland Bassett, Brett Carter, Adil Daud,[...]. Lancet Oncol 2019
89
6

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.
Christian U Blank, Elisa A Rozeman, Lorenzo F Fanchi, Karolina Sikorska, Bart van de Wiel, Pia Kvistborg, Oscar Krijgsman, Marlous van den Braber, Daisy Philips, Annegien Broeks,[...]. Nat Med 2018
353
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.